1911. A Pilot Study to Evaluate the Effectiveness of Nasal and Oral Povidone Iodine in Reducing the Burden of Severe Acute Respiratory Syndrome 2 RNA in Patients with COVID-19

BACKGROUND: Nasal and oral application of topical antiseptics such as povidone iodine could potentially reduce the risk for transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, limited information is available on the efficacy of such agents in reducing the burden of...

Descripción completa

Detalles Bibliográficos
Autores principales: Redmond, Sarah, Jones, Lucas D, Nguyen, Alexandria, Ghaddara, Hussein, Cadnum, Jennifer, Donskey, Curtis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752924/
http://dx.doi.org/10.1093/ofid/ofac492.1538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752924/
http://dx.doi.org/10.1093/ofid/ofac492.1538

Ejemplares similares